Among a growing number of Americans seeking general health information and information about cancer, the Internet remains a frequent first source, even though the public’s trust in online material about health has declined, reports a government study. At the same time, consumers voiced greater confidence in information received from healthcare professionals. The report, Cancer Communication: […]

Researchers have identified molecular changes in multiple myeloma cells that activate an important biological pathway associated with cell growth and survival, thereby revealing potential new targets for drugs to treat this cancer.  The researchers, led by a team from the National Cancer Institute (NCI), part of the National Institutes of Health, have shown that malignant […]

Adolescents who see smoking depicted in movies are more likely to become established smokers, according to a study funded by the National Cancer Institute (NCI), part of the National Institutes of Health. The study, which could have broad implications for efforts to reduce smoking among youth, appears in the November 2005 issue of the journal […]

Several protease inhibitors that are used in combination with other drugs to treat Human Immunodeficiency Virus (HIV) infection may also be effective against certain types of cancer, according to researchers from the National Cancer Institute (NCI), part of the National Institutes of Health.  Nelfinavir (Viracept®), Ritonavir (Norvir®), and Saquinavir (Invirase®) inhibited growth of several types […]

Laboratory experiments show that an extract of the skin of muscadine grapes can inhibit growth of prostate cancer cells in the laboratory. Investigators from the National Cancer Institute (NCI), part of the National Institutes of Health, and their research partners also show that muscadine grape skin extract (MSKE) does not contain significant amounts of resveratrol, […]

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is funding a new $15.5 million, five-year initiative to discover, develop, and clinically validate cancer biomarkers by targeting the carbohydrate (glycan) part of a molecule.  Biomarkers are substances sometimes found in the blood, other body fluids, or tissues that measure biological processes, […]

Researchers have discovered that a protein called ATM kinase, which plays a crucial role in repairing double-strand breaks in DNA, also helps prevent cells with this type of DNA damage from dividing, thereby blocking the passage of persistent DNA damage on to daughter cells. Persistent DNA damage can lead to the development of cancer. These […]

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), today launched the three-year pilot phase of a new program that will help bring state-of-the-art cancer care to patients in community hospitals across the United States.

A team of researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has uncovered a set of genes that are turned on, or expressed, at high levels only in the blood vessels that feed tumors in mice and humans. These genes, and the proteins they encode, are important new […]

A new compound, called ABT-888, has passed the first stage of clinical examination using a new model for drug development that promises to shorten — by up to six to 12 months — the timeline for taking anticancer drugs from the laboratory to the clinic, according to a team of researchers at the National Cancer […]